Codexis share price logo

Codexis

NASDAQ: CDXS

$1.33

+0.04

(+3.49%)

Live

as on

Codexis Stock Performance

as on October 16, 2026 at 5:10 am IST

  • Day's Low

    Day's High

    $1.26
    $1.35
    downward going graph

    5.26%

    Downside

    1.50%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.96
    $2.98
    downward going graph

    27.95%

    Downside

    124.06%

    Upside

    downward going graph

Codexis share price movements today

Previous Close
$1.29
Open
$1.27
Volume
1.1M
Market Cap
$144.5M
Day's Low - High
$1.26 - $1.35
52 Week Low - High
$0.96 - $2.98

Codexis Historical Returns

1 Month Return
-7.86 %
3 Month Return
-41.63 %
1 Year Return
-52.92 %
3 Year Return
-35.18 %
5 Year Return
-95.45 %

Codexis Stock Fundamentals & Key Indicators

Check Codexis market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$144.5M

EPS (TTM)

-0.3359

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.93

Industry PE ratio

-3.10

PEG Ratio

-0.04

EBITDA

-20.7M

Revenue (TTM)

77.7M

Profit Margin

83.71%

Return On Equity TTM

-74.36%

Codexis vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Codexis with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$144.5M-95.45%-3.9383.71%0.00%
Neutral$86.3B-30.20%-28.20-12.57%0.00%
StrongBuy$123.0B174.25%28.0286.04%0.00%
Buy$78.5B40.69%17.8384.86%0.49%

Stock Returns calculator for Codexis Stock including INR - Dollar returns

The Codexis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Codexis investment value today

Current value as on today

₹52,545

Returns

-₹47,455

(-47.45%)

Returns from Codexis Stock

-₹51,460 (-51.46%)

Dollar Impact

₹4,005 (+4%)

Analyst Recommendation on Codexis Stock

Based on 4 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 4 analysts, 75% of analysts recommend a 'BUY' rating for Codexis. Average target price of $6.14

Codexis Share Price Target

Get share price movements and forecasts by analysts on Codexis.

What analysts predicted

78.34%UPSIDE

Target Price

$6.14

Current Price

$1.33

Analyzed by

4 Analysts

High

$11

Target

$6.14

Low

$2

Codexis target price $6.14, a slight upside of 78.34% compared to current price of $1.33. According to 4 analysts rating.

Indian Investors' Interest in Codexis Stock

Search interest for Codexis Stock has increased by 12% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:12% versus previous 30 day period

Codexis Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
17
7
12
21
7
15
8
38
15
14
Gross Profit
10
4
8
17
4
11
6
35
11
11
Operating Income
-11
-22
-16
-7
-20
-12
-18
13
-8
-11
EBITDA
-9
-19
-13
-8
-17
-11
-16
11
-6
-9
Interest Expense
-
0
4
-6
0
-
1
-
-
-
Depreciation
2
2
2
2
1
2
2
2
2
2
Income Before Tax
-11
-22
-20
-10
-20
-13
-19
9
-8
-11
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-11
-22
-20
-10
-20
-13
-19
9
-8
-12
Net Profit Margin
64.23%
56.61%
66.36%
82.97%
63.78%
77.82%
71.34%
91.36%
78.28%
76.45%

Codexis Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
50
60
68
69
104
138
70
59
70
Gross Profit
35
47
52
55
82
100
57
43
61
Operating Income
-22
-11
-12
-23
-22
-34
-68
-58
-38
EBITDA
-21
-10
-7
-19
-15
-21
-44
-53
-33
Interest Expense
-
-
-
-
-
-
-
-
4
Depreciation
1
1
4
4
5
10
9
4
5
Income Before Tax
-22
-10
-11
-23
-21
-33
-76
-65
-43
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-22
-10
-11
-24
-21
-33
-76
-65
-43
Net Profit Margin
71.36%
79.17%
77.17%
80.10%
78.80%
72.56%
81.74%
72.55%
86.73%

Codexis Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-11
-22
-20
-10
-20
-13
-19
9
-8
-12
Operating Cash Flow
-7
-12
-12
-16
-13
-17
-7
20
-13
-9
Investing Cash Flow
-28
-27
1
-2
11
0
6
5
-1
0
Financing Cash Flow
29
0
30
1
1
26
0
0
0
0
Change in Cash
-7
-39
18
-18
0
8
-1
25
-14
-9

Codexis Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-22
-10
-11
-24
-21
-33
-76
-65
-43
Operating Cash Flow
-8
-14
-12
-16
-14
11
-52
-49
-19
Investing Cash Flow
0
-2
-3
-5
-21
-13
-4
-56
23
Financing Cash Flow
21
38
53
80
3
0
8
60
27
Change in Cash
11
21
37
58
-31
-2
-49
-45
32

Global Institutional Holdings in Codexis

Check out the Institutions with significant holdings in Codexis.

Funds
Holdings
iShares
4.35%
Vanguard
4.19%
VANGUARD INDEX FUNDS
3.21%
COLUMBIA FUNDS SERIES TRUST I
2.45%
Columbia Funds Series Trust I
1.55%

Insights on Codexis

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 716.4% return, outperforming this stock by 769.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 130.2% return, outperforming this stock by 165.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, CDXS stock has moved down by -41.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 9.60M → -12.00M (in $), with an average decrease of 114.3% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 38.91M → 14.91M (in $), with an average decrease of 31.5% per quarter

About Codexis

Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engineering technology platform. This innovative platform is instrumental in crafting and delivering high-performance biocatalysts capable of driving chemical transformations, thereby significantly enhancing the efficiency and productivity of manufacturing processes. Beyond industrial applications, the CodeEvolver platform is also leveraged for identifying novel biotherapeutic drug candidates for targeted human diseases, as well as for developing enzymes essential for molecular biology research and in vitro diagnostic applications. Primarily serving pharmaceutical manufacturers, Codexis distributes its products through its dedicated direct sales and business development teams across the United States and Europe. Established in 2002, the company maintains its headquarters in Redwood City, California.
OrganisationCodexis
Headquarters200 Penobscot Drive, Redwood City, CA, 94063, US
IndustryBiotechnology
CEOAlison Moore

Key Management of Codexis

Name

Title

Dr. Alison Moore Ph.D.

President, CEO & Director

Ms. Georgia L. Erbez

CFO & Chief Business Officer

Dr. Stefan Lutz Ph.D.

Chief Scientific Officer

Mr. Britton Jimenez

Senior Vice President of Sales & Marketing

Ms. Karen Frechou-Armijo

Senior VP & Head of Human Resources

Mr. John Schiffhauer

Senior Vice President of Intellectual Property

FAQs

What is Codexis share price today?

Codexis share price today is $1.33 as on . Codexis share today touched a day high of $1.35 and a low of $1.26.

What is the 52 week high and 52 week low for Codexis share?

Codexis share touched a 52 week high of $2.98 on and a 52 week low of $0.96 on . Codexis stock price today i.e. is trending at $1.33,which is 55.37% down from its 52 week high and 38.79% up from its 52 week low.

What is Codexis's market capitalisation today?

Codexis market capitalisation is $0.00T as on .

How to invest in Codexis Stock (CDXS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Codexis on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Codexis Stock (CDXS) from India?

Indian investors can start investing in Codexis (CDXS) shares with as little as ₹95.05500030517578 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹950.55 in Codexis stock (as per the Rupee-Dollar exchange rate as on ). Based on Codexis share’s latest price of $1.33 as on October 15, 2026 at 11:40 pm IST, you will get 7.5188 shares of Codexis. Learn more about fractional shares .

What are the returns that Codexis has given to Indian investors in the last 5 years?

Codexis stock has given -95.45% share price returns and 27.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?